GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biosino Bio-Technology and Science Inc (HKSE:08247) » Definitions » COGS-to-Revenue

Biosino Bio-Technology and Science (HKSE:08247) COGS-to-Revenue : 0.68 (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Biosino Bio-Technology and Science COGS-to-Revenue?

Biosino Bio-Technology and Science's Cost of Goods Sold for the three months ended in Dec. 2023 was HK$58.0 Mil. Its Revenue for the three months ended in Dec. 2023 was HK$85.9 Mil.

Biosino Bio-Technology and Science's COGS to Revenue for the three months ended in Dec. 2023 was 0.68.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Biosino Bio-Technology and Science's Gross Margin % for the three months ended in Dec. 2023 was 32.45%.

Biosino Bio-Technology and Science COGS-to-Revenue Historical Data

The historical data trend for Biosino Bio-Technology and Science's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosino Bio-Technology and Science COGS-to-Revenue Chart

Biosino Bio-Technology and Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.66 0.59 0.61 0.56

Biosino Bio-Technology and Science Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.55 0.49 0.51 0.68

Biosino Bio-Technology and Science COGS-to-Revenue Calculation

Biosino Bio-Technology and Science's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=176.873 / 316.182
=0.56

Biosino Bio-Technology and Science's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=58.01 / 85.871
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosino Bio-Technology and Science  (HKSE:08247) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Biosino Bio-Technology and Science's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 58.01 / 85.871
=32.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Biosino Bio-Technology and Science COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biosino Bio-Technology and Science's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosino Bio-Technology and Science (HKSE:08247) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biosino Bio-Technology and Science Inc (HKSE:08247) » Definitions » COGS-to-Revenue
Comparable Companies
HKSE:08225 HKSE:00928 HKSE:08037 TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN LH SHSE:603259 DGX RVTY NTRA XPAR:BIM MEDP
Traded in Other Exchanges
N/A
Address
No. 27 Chaoqian Road, Science and Technology Industrial Park, Changping District, Beijing, CHN, 102200
Website
http://www.zhongsheng.com.cn
Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale, and distribution of in-vitro diagnostic (IVD) reagent products. the company's revenue is generated from customers located in Mainland China.
Executives
Beijing Enterprises Group Company Limited 2201 Interest of corporation controlled by you
Beijing Enterprises Holdings Limited 2101 Beneficial owner
Hk Zhixin Investment Co., Ltd. 2101 Beneficial owner
Li Dongfeng 2201 Interest of corporation controlled by you
Yan Kang 2201 Interest of corporation controlled by you
Qiu Zhe Feng 2201 Interest of corporation controlled by you
Hai Nan Zhi Xin Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Yun Nan Sheng Neng Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Li Yang Yi Xiong 2201 Interest of corporation controlled by you

Biosino Bio-Technology and Science (HKSE:08247) Headlines

No Headlines